Product Information
ROPINIROLE HCL ER 8 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $1.0184 per EA under NDC 62332011090. Its NADAC has been published 284 times since Mar 17, 2021.
FDA first approved this application on Apr 22, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
8 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332011090
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202786FDA Approved
4/22/2013
TE Code
AB
On Market Since
6/20/2020
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL ER 8 MG TABLET has been published 284 times since Mar 17, 2021, and over the history we have for it it has declined 53.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0184 per EA |
|---|---|
| All-time high | $2.4621 (Jul 14, 2021) |
| All-time low | $0.7082 (Nov 23, 2022) |
| 52-week high | $1.5166 |
| 52-week low | $0.7180 |
| Median price | $1.4174 |
| Average price | $1.4414 |
| Largest weekly change | +104.0% (Dec 21, 2022) |
| Weeks tracked | 284 |
| Tracking since | Mar 17, 2021 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL ER 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL ER 8 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $1.0184 per EA (NDC 62332011090), effective Aug 19, 2026.
How has the price of ROPINIROLE HCL ER 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL ER 8 MG TABLET has declined 53.9%. It has been tracked across 284 weekly CMS publications since Mar 17, 2021.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL ER 8 MG TABLET?
Since Mar 17, 2021, the NADAC for ROPINIROLE HCL ER 8 MG TABLET has ranged from a low of $0.7082 (Nov 23, 2022) to a high of $2.4621 (Jul 14, 2021), with a median of $1.4174 per EA.
Are there cheaper alternatives to ROPINIROLE HCL ER 8 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ROPINIROLE HCL ER 8 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ROPINIROLE HCL ER 8 MG TABLET?
ROPINIROLE HCL ER 8 MG TABLET (NDC 62332011090) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.